产品说明
一般描述
Metabolite of vitamin D3 via a single cytochrome P450-mediated hydroxylation. Further metabolized to 1α,2,5-dihydroxy Vitamin D by a second cytochrome P450- mediated-hydroxylation. Major circulating metabolite of vitamin D3.
Metabolite of vitamin D3 via a single cytochrome P450-mediated hydroxylation. Further metabolized to 1α, 25-dihydroxy vitamin D by a second cytochrome P450-mediated hydroxylation. A major circulating metabolite of vitamin D3.
包装
1 mg in Alu drum
Packaged under inert gas
警告
Toxicity: Toxic & Carcinogenic / Teratogenic (G)
重悬
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 4 months at -20°C.
其他说明
DeLuca, H.F., and Schnoes, H.K. 1983. Annu. Rev. Biochem.52, 411.
Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
法律信息
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
基本信息
| 经验(实验)分子式 | C27H44O2 |
| 分子量 | 400.64 |
| MDL编号 | MFCD00867077 |
产品性质
| 质量水平 | 100 |
| 测定 | ≥99% (LC/MS) |
| 形式 | powder |
| manufacturer/tradename | Calbiochem® |
| 储存条件 | OK to freeze |
| 颜色 | white |
| 溶解性 | ethanol: 10 mg/mL |
| 运输 | wet ice |
| 储存温度 | −20℃ |
| InChI | 1S/C27H44O2/c1-19-10-13-23(28)18-22(19)12-11-21-9-7-17-27(5)24(14-15-25(21)27)20(2)8-6-16-26(3,4)29/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3/b21-11+,22-12-/t20-,23+,24-,25+,27-/m1/s1 |
| InChI key | JWUBBDSIWDLEOM-DTOXIADCSA-N |
安全信息
| 象形图 |   |
| 警示用语： | Danger |
| 危险声明 | H301 + H311 - H330 - H372 |
| 预防措施声明 | P260 - P264 - P280 - P302 + P352 + P312 - P304 + P340 + P310 - P314 |
| 危险分类 | Acute Tox. 2 Inhalation - Acute Tox. 3 Dermal - Acute Tox. 3 Oral - STOT RE 1 Oral |
| 储存分类代码 | 6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
m.cnreagent.com
